EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation

por Diefenbach, Konstanze, Trummer, Dietmar, Ebert, Frank, Lissy, Michael, Koch, Manuela, Rohde, Beate, Blode, Hartmut
Publicado 2013

Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women

por Schütt, Barbara, Schultze‐Mosgau, Marcus‐Hillert, Draeger, Corinna, Chang, Xinying, Löwen, Stephanie, Kaiser, Andreas, Rohde, Beate
Publicado 2017

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial

por Schultze‐Mosgau, Marcus‐Hillert, Schütt, Barbara, Draeger, Corinna, Casjens, Manuela, Loewen, Stephanie, Zimmermann, Torsten, Rohde, Beate
Publicado 2020

Topical administration of regorafenib eye drops: phase I dose‐escalation study in healthy volunteers

por Zimmermann, Torsten, Höchel, Joachim, Becka, Michael, Boettger, Michael K., Rohde, Beate, Schug, Barbara, Kunert, Kathleen S., Donath, Frank
Publicado 2018

Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women

por Liu, Hongzhong, Jiang, Ji, Chen, Zhaozhao, Zhang, Yunhui, Li, Jinyi, Hoechel, Joachim, Rohde, Beate, Zimmermann, Torsten, Schultze‐Mosgau, Marcus‐Hillert
Publicado 2020

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension

por Gessler, Tobias, Ghofrani, Hossein-Ardeschir, Held, Matthias, Klose, Hans, Leuchte, Hanno, Olschewski, Horst, Rosenkranz, Stephan, Fels, Lueder, Li, Na, Ren, Dawn, Kaiser, Andreas, Schultze-Mosgau, Marcus-Hillert, Müllinger, Bernhard, Rohde, Beate, Seeger, Werner
Publicado 2017